[144] QuantumScape Corporation SEC Filing

Rhea-AI Filing Summary

An individual affiliated with QuantumScape Corporation (QS) filed a Form 144 to sell 46,837 shares of Class A common stock on or about 08/18/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The shares were acquired on 08/15/2025 by RSU vesting and were recorded as compensation; the filer lists 72,056 shares as the amount acquired on that date. The aggregate market value of the proposed sale is $422,938.11 and total outstanding shares are shown as 522,939,205. The filer reports no sales of issuer securities in the past three months and certifies they lack undisclosed material adverse information.

Insights

Securities Compliance Analyst

Routine insider sale following RSU vesting; compliance filing appears standard and timely.

The Form 144 discloses a proposed sale of 46,837 Class A shares through a broker with full aggregation and acquisition details provided. The shares were acquired by RSU vesting and paid as compensation, which is a common source of Form 144 sales. The filer certifies no undisclosed material adverse information. Given the small size of the sale relative to the stated outstanding shares (46,837 of 522,939,205), this disclosure is unlikely to be material to market valuation but satisfies Rule 144 notice requirements.

Equity Compensation Specialist

Transaction consistent with routine monetization of vested RSUs; minimal market impact expected.

The filing shows acquisition on 08/15/2025 via RSU vesting and a near-term sale date of 08/18/2025 with proceeds of approximately $422,938.11. The filing notes 72,056 shares were acquired on vesting and 46,837 are being sold, implying partial monetization of recently vested awards. This is a typical liquidity event for recipients of equity compensation and does not in itself indicate operational or financial issues at the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th floor New York NY 10004	46837	422938.11	522939205	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/15/2025	RSU vesting	Issuer			72056	08/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by QS disclose?

The filing discloses a proposed sale of 46,837 Class A common shares on 08/18/2025 through Morgan Stanley Smith Barney LLC with an aggregate market value of $422,938.11.

How were the shares acquired that are being sold in the QS Form 144?

The shares were acquired on 08/15/2025 as the result of RSU vesting and were recorded as compensation.

Does the Form 144 report any other sales in the past three months for QS?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the QS shares be sold?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th floor, New York, NY 10004.

What assurances does the filer provide about material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.